Intellia, CRISPR-based and Gene Editing
Digest more
Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...
As cell and gene therapy leaders gathered in Maryland to discuss accelerating clinical trials in children, one “cutting edge” ...
That is because scientists keen to achieve more precise control over an organism’s genetics are experimenting with a ...
Gene therapy has long promised to provide a solution for genetic blood disorders, but delivering on that promise has proven complex due to challenges including difficulties delivering the editing ...
Science and medicine are incredibly amazing. Thanks to modern science and medicine, we now have lifespans far beyond our Dark Age predecessors, living until ripe old age and enjoying the fruits of our ...
Gene editing has emerged as a powerful approach for targeting the genetic causes of disease, but getting the editing ...
With Phase 3 data in hand, Intellia Therapeutics is seeking approval for its in vivo CRISPR gene editing therapy for ...
Profluent and Lilly teamed up on AI‑designed enzymes in a deal worth up to $2.25B. Big tech, bigger gene edits.
Researchers in Mexico are turning their focus towards a revolutionary technique to enhance crop resilience. According to News Arena India, the International Maize and Wheat Improvement Center, also ...
Find the latest Gene Editing news from WIRED. See related science and technology articles, photos, slideshows and videos.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results